George Klinger

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

Bertram Pitt, Philip A. Poole‐Wilson, Robert Segal et al. · The Lancet · 2000 · 2K citations

Medicine, Cardiology, Internal Medicine +9

Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy

David Warr, Paul J. Hesketh, Richard J. Gralla et al. · Journal of Clinical Oncology · 2005 · 465 citations

Medicine, Oncology, Pharmacology +17

Losartan in Heart Failure

Ian Crozier, Hamid Ikram, Najam A. Awan et al. · Circulation · 1995 · 292 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the losartan heart failure survival study-ELITE II

Bertram Pitt, Philip Poole‐Wilson, Robert Segal et al. · Journal of Cardiac Failure · 1999 · 91 citations

Medicine, Cardiology, Internal Medicine +9

The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis

Manal F. Abdelmalek, Edgar D. Charles, Arun J. Sanyal et al. · Contemporary Clinical Trials · 2021 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17